Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of coumarin compound targeting β-amyloid protein and its preparation and application

A technology of amyloid and coumarin, applied in the direction of isotope introduction of organic compounds, heterocyclic compound isotope introduction, preparations for in vivo tests, etc., can solve the problem of no drug available, and achieve the effect of simple preparation method

Active Publication Date: 2021-07-16
XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE +1
View PDF14 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no PET imaging agent targeting Aβ in China that has been approved for marketing. There is no drug available for the early diagnosis and efficacy evaluation of AD in China. The development of new PET imaging drugs targeting Aβ can fill the gap in my country's biopharmaceutical industry. field blank

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of coumarin compound targeting β-amyloid protein and its preparation and application
  • A kind of coumarin compound targeting β-amyloid protein and its preparation and application
  • A kind of coumarin compound targeting β-amyloid protein and its preparation and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Compound A(R 1 for CH 3; 2 for C 2 h 4 ) preparation of coumarin compound

[0032] Take K 222 (10-12mg) and potassium carbonate (1-2mg) in acetonitrile solution enriched [ 18 F]F - The QMA column (2mCi) was collected into the reaction bottle, and the reaction bottle was placed at 90°C, blown dry by blowing nitrogen gas (1mL / min), then added anhydrous acetonitrile solvent and evaporated to dryness, repeated three times, and added 0.6mL anhydrous DMF . Add 0.3mL containing 2mg of precursor compound B (R 1 for CH 3 ; 2 for C 2 h 4 ) in anhydrous DMF solution, sealed reaction at 120°C for 30min, and cooled to room temperature after the reaction.

[0033] Add 5mL of pure water to the reaction product and pass through a sep-pak C18 column in advance, and then use a semi-preparative C18 column for separation and purification, such as figure 1 As shown, the peak at t=8.1min is unreacted 18 f - The characteristic peak at t=25.5min is the product peak. Collect the...

Embodiment 2

[0042] Embodiment 2 PET imaging

[0043] prepared by the above method 18 F-labeled coumarin compound A for micro-PET imaging

[0044] AD model mice and normal control mice were injected into the tail vein prepared by the above method 18 F-labeled coumarin compound A, after isoflurane inhalation anesthesia, use a heating module to keep its body temperature at about 37°C, use R4micro-PET to scan dynamically for 2 hours, and divide the data into frames after the end of data collection (the first half hour, 2 minutes / frame; 10 minutes / frame), using the OSEM3D method for image reconstruction, using Inveon Research Workplace 2.2 (IRW, Siemens) software to manually select each region of interest (ROI) in the brain region, and calculate the SUV. Its image is shown in Figure 3. It can be seen from the figure that the pairing in the brain of AD model rats 18 F-labeled coumarin compound A was significantly concentrated, compared with no concentration in normal mice.

[0045] Example...

Embodiment 3

[0057] A method for preparing a coumarin compound targeting β-amyloid, comprising the following steps:

[0058] 1. What will be obtained contains 18 f - H 2 18 O solution was enriched by QMA column 18 f - , use the solution containing phase transfer catalyst, potassium salt to wash the QMA column to obtain phase transfer catalyst, potassium salt and 18 f - The mixed solution, said containing phase transfer catalyst, potassium salt and 18 f - The ratio of the amount of substance of each component in the mixture is: phase transfer catalyst: potassium salt=7.5:1, 18 f - The activity is 2Ci. in 18 f - From bombardment of H with a cyclotron 2 18 O target income.

[0059] 2. In an organic solvent (anhydrous tetrahydrofuran), under the protection of an inert gas (nitrogen), the phase-transfer catalyst K 222 , potassium carbonate and 18 f - H 2 18The O solution was subjected to nucleophilic substitution reaction with compound B at a reaction temperature of 120° C. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a coumarin compound targeting β-amyloid protein and its preparation method and application. The structural formula of the coumarin compound targeting β-amyloid protein is as follows: wherein, R 1 for CH 3 or CF 3 ; 2 for C 2 h 4 or C 3 h 6 straight-chain alkyl groups. The compound uses compound B as a labeling precursor, and 18 f ‑ It is prepared by nucleophilic substitution reaction. Compared with the prior art, the present invention can fill the gap in the field of early diagnosis and curative effect evaluation of AD by using radiopharmaceuticals in my country. And as a specific Alzheimer's disease PET imaging probe. The preparation method of the present invention is simple, suitable for the clinical application of radiopharmaceuticals, and the prepared 18 The radiochemical purity of the F-labeled compound is greater than 95%.

Description

technical field [0001] The invention relates to coumarin compounds, in particular to a coumarin compound targeting β-amyloid protein and its preparation and application. Background technique [0002] β-amyloid protein ((β-amyloid protein, Aβ)) in the brain is derived from its precursor substance β-amyloid precursor protein (APP). It has been confirmed that Aβ is derived from gene-encoded APP, with a molecular weight of about 4kD, all of which are transmembrane glycoproteins, and have a β-sheet in a three-dimensional structure, so it is called "β-amyloid protein". Aβ consists of 28 amino acids outside the APP cell membrane and 12 amino acids in the transmembrane part, located in the hydrophobic part of APP. Has a strong aggregation, easy to form extremely difficult to dissolve precipitate. Aβ is the main component of senile plaques and is a neuropathological marker (Glenner G G. Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D491/052C07B59/00A61K51/04A61K101/02
CPCA61K51/0453C07B59/002C07B2200/05C07D491/052
Inventor 王辉曹本红梁胜
Owner XIN HUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE